Results 11 to 20 of about 5,481 (205)

Pararectal Migration of a Malleable Rod: An Unusual Late Complication [PDF]

open access: yesThe World Journal of Men's Health, 2016
A 75-year-old male had failed to respond conservative therapy for erectile dysfunction and had undergone insertion of a malleable penile prosthesis in 1995.
Ibrahim Kucukturkmen   +6 more
doaj   +1 more source

Penile Prosthesis in Transgender Men after Phalloplasty

open access: yesIndian Journal of Plastic Surgery, 2022
A penile prosthesis can be successfully implanted after phalloplasty in transgender men to permit sexual intercourse. A prosthesis can be categorized as malleable or inflatable.
Rajveer S. Purohit   +2 more
doaj   +1 more source

Ferroelectrets: Recent developments

open access: yesIET Nanodielectrics, Volume 5, Issue 3-4, Page 113-124, September-December 2022., 2022
Abstract Ferroelectrets (also called piezoelectrets) are relatively young members in the family of piezo‐, pyro‐ and ferroelectric materials. They exhibit ferroic behaviour phenomenologically undistinguishable from that of traditional ferroelectrics, although the materials per se are essentially non‐polar space‐charge electrets with artificial ...
Xunlin Qiu   +6 more
wiley   +1 more source

Peyronie's disease development and management in diabetic men

open access: yesAndrology, Volume 11, Issue 2, Page 372-378, February 2023., 2023
Abstract Background Peyronie's disease (PD) is a fibrosing disorder of the penis resulting in plaque formation and penile deformity that negatively affect sexual and psychosocial function of patients. A multifactorial etiology of PD is assumed with diabetes mellitus (DM) being a potential risk factor.
Simone Gianazza   +11 more
wiley   +1 more source

The management of erectile dysfunction in men with diabetes mellitus unresponsive to phosphodiesterase type 5 inhibitors

open access: yesAndrology, Volume 11, Issue 2, Page 257-269, February 2023., 2023
Abstract Introduction Erectile dysfunction is associated with diabetes mellitus with an estimated prevalence of 52.5% in the diabetic population. The first‐line therapy for erectile dysfunction is phosphodiesterase type 5 inhibitors, but data suggest that diabetic men may be less responsive than non‐diabetic men.
Axel Alberto Cayetano‐Alcaraz   +4 more
wiley   +1 more source

Identification of hub biomarkers and exploring the roles of immunity, M6A, ferroptosis, or cuproptosis in rats with diabetic erectile dysfunction

open access: yesAndrology, Volume 11, Issue 2, Page 316-331, February 2023., 2023
Abstract Background Currently, patients with diabetic erectile dysfunction (DMED) were not satisfied with the effects of first‐line phosphodiesterase type 5 inhibitors (PDE5Is). Hence, this paper was designed to mine hub biomarkers in DMED and explore its potential mechanisms.
Yi Wang   +4 more
wiley   +1 more source

First reported case of penile prosthesis infection from brucellosis: case report

open access: yesAfrican Journal of Urology, 2020
Background Infection after the penile prosthesis can be devastating to both the patient and surgeon with various complications and consequences. After introduction of antibiotic-coated implants, the rate of infection has dramatically decreased, but still
Nabil Nabil Moohialdin   +5 more
doaj   +1 more source

Malfunctioned and Fractured Penile Prosthesis Caused by Cross Placement: Case Report

open access: yesUrology Case Reports, 2015
Penile prosthesis is a functional option for patients who have erectile dysfunction after failed medical and intracavernosal treatments. Malleable penile prosthesis is a good alternative. Penile prosthesis implantation is a surgical process.
Nihat Karakoyunlu   +6 more
doaj   +1 more source

Outcomes of low-flow priapism and role of integrated penile prosthesis management

open access: yesAfrican Journal of Urology, 2021
Background The natural history of priapism and predictors of erectile dysfunction (ED) remain vague due to defective reporting, different management techniques and variable follow-up durations.
Mamdouh M. Elhawy, A. M. Fawzy
doaj   +1 more source

Population designations in biomedical research: Limitations and perspectives

open access: yesHLA, Volume 101, Issue 1, Page 3-15, January 2023., 2023
In biomedical research, population differences are of central interest. Variations in the frequency and severity of diseases and in treatment effects among human subpopulation groups are common in many medical conditions. Unfortunately, the practices in terms of subpopulation labeling do not exhibit the level of rigor one would expect in biomedical ...
Caroline Gombault   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy